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Abstract
A large group of small Rab GTPases which mediate secretory and endosomal membrane transport, as well as
autophagosome biogenesis, are essential components of vesicle trafficking machinery. Specific Rab protein
together with the cognate effectors coordinates the dynamics of trafficking pathway and determines the cargo
proteins destination. Functional impairments of Rab proteins by mutations or post-translational modifications
disrupting the regulatory network of vesicle trafficking have been implicated in tumorigenesis. Therefore, the
vesicle transport regulators play essential roles in the mediation of cancer cell biology, including uncontrolled cell
growth, invasion and metastasis. The context-dependent role of the same Rab to act as either an oncoprotein or
tumor suppressor in different cancers is found. Such discrepancies may be due in part to the interaction of
specific Rab protein with different effectors or cargos in various tumors. Here, we review recent advances in the
roles of Rab GTPases in communicating with other effectors in tumor progression. In this review, we also
emphasize dysregulation of Rab-mediated membrane delivery shifting normal cell behaviors toward malignancy.
Thus, recovery of the dysregulated vesicle trafficking systems in cancer cells may provide future directions for
potential strategy to restrain tumor progression.
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Background
Rab proteins are evolutionarily conserved with 55–75%
identity across species. They are small GTPases compris-
ing more than 70 members in humans and function as
regulators of vesicles transport, proteins trafficking, mem-
brane targeting and fusion [1–3]. Rab protein activity is
controlled by cycling between the active GTP-bound and
inactive GDP-bound forms. Guanine nucleotide exchange
factors (GEFs) serve as the effectors of Rab GTPase by
facilitating the exchange of GDP for GTP, resulting in the
activation of Rabs and the downstream signaling [4]. In
contrast, GTPase-activating proteins (GAPs) catalyze the
hydrolysis of GTP to GDP to convert the GTP-bound
Rabs to inactive GDP-bound form [5]. Some Rab small
GTPases localize to the cytosol by forming complex with
guanine dissociation inhibitors (GDIs) that prevent
their membrane anchorage. Other effectors such as
motor proteins, tethering factors and SNAREs (Soluble
N-ethylmaleimide sensitive factor attachment protein re-
ceptor) are involved in the coordination of Rabs-mediated
vesicle transport from donor membrane budding toward
acceptor membrane fusion [6–8]. Dysregulation in Rabs
level or mutations altering GTP/GDP-binding of Rabs or
Rabs interaction with effectors may dampen the efficiency
and specificity in membrane traffic that are implicated in
disease development such as cancer.
In recent years, advanced progress in understanding the
cellular functions of Rabs on vesicle trafficking has been
made. Therefore, this review provides an overview of our
current knowledge of regulation of Rab-mediated vesicle
dynamics, and their critical roles in tumorigenesis.
Rab GTPases function as molecular switches in membrane
traffic
Over the past two decades, emerging evidence has
shown that distinct classes of small GTPases are in-
volved in membrane vesicles trafficking. Individual Rab
protein localizes to the surface membrane of different
organelle in the cytosolic compartment and regulates a
specific membrane trafficking pathway for appropriate
protein sorting and targeting. Most Rabs are expressed ubi-
quitously, while some have tissue/cell-type specificity. For
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example, Rab17 is predominantly expressed in epithelial
cells and localized to apical recycling endosome (ARE) to
mediate transcytosis to the basolateral plasma membrane
[9]. Rab15 and Rab25 are also involved in the transporta-
tion of cargos through the ARE system [10, 11]. Rab12 is
highly expressed in Sertoli cells and is responsible for the
cargo delivery from peripheral to the perinuclear region to
maintain centrosomes integrity [12]. Rab10 is expressed in
adipocytes and implicated in mediating insulin-stimulated
plasma membrane translocation of glucose transporter
GLUT4 [13]. Rab8A and Rab13 are expressed in skeletal
muscle cells and become active forms in response to insu-
lin stimulation [14].
Some Rabs localize at different subcellular organelles. For
instance, localization of Rab33 at the medial Golgi helps in
the intra-Golgi transportation of vesicles [15]. Rab5 and
Rab21 are involved in early endosome transport and
mediate endocytosis pathway while Rab7 regulates cargo
trafficking from early endosome to late endosome and
subsequently to lysosome for degradation [16–18]. Another
vesicle transport route is from trans-Golgi network (TGN)
to the plasma membrane, which is mediated by secretory
granules and vesicles. A lot of Rab proteins are associated
with exocytic pathway including Rab3, Rab11, Rab26,
Rab27, Rab37 and Rab38 [19–24]. Vesicles transport
between TGN and early endosome are controlled by Rab22
and Rab31 [25, 26]. The diversity of individual Rab binding
partner determines the specific vesicle transport route and
creates the complexity of membrane trafficking.
Autophagy is responsible for degradation of intracellu-
lar components by transporting them to lysosomes to
maintain cellular homeostasis and prevent pathogens in-
fection. Rab proteins are also involved in the regulation
of autophagy biogenesis [27]. Rab5, for example, partici-
pates in autophagy induction by the sequential signaling
cascade in response to growth factor [28]. Overexpres-
sion of Rab32 promotes autophagosome biogenesis [29].
Rab33 has also been reported to regulate autophago-
some formation through interaction with ATG16L, an
essential factor for LC3 lipidation and membrane bio-
genesis in autophagy [30]. Several Rabs including Rab7,
Rab11, Rab24 and Rab25 play critical roles in modulat-
ing autophagosome maturation [31–34]. In ovarian can-
cer cells, knockdown of Rab25 increases the conversion
of LC3-I to LC3-II, a critical step for autophagy, and in-
duces apoptosis. These results indicate a role of Rab25
in tumorigenesis relevant to autophagy suppression [34].
Emerging evidence has shown that exosomes act as a
novel mode of intercellular communication. They deliver
message from cancer cells to surrounding stromal cells as
well as distant metastatic sites to create a pre-metastatic
niche [35]. Exosome secretion is regulated by fusion of the
plasma membrane with multivesicular bodies (MVBs),
which are late endosomal structure of endocytic pathway
containing intraluminal vesicles. It has been observed that
Rab proteins critically contribute to exsosome release. For
example, Rab11 regulates transferrin receptor secretion
via the exosome pathway [36]. Similarly, Rab35 pro-
motes exosome release by interacting with its effector
TBC1D10A-C [37]. The role of Rabs in regulation of
exosome pathway also has been explored in association
with tumor progression. Indeed, Rab27-dependent exo-
some secretion of microRNAs is linked to tumor inva-
siveness in bladder cancer [38].
Dysregulated Rab GTPases implicated in cancer
Emerging evidence show that aberrant expression of Rab
GTPases is closely associated with tumorigenesis (Fig. 1).
Indeed, a set of Rab proteins including Rab1, Rab2A,
Rab3D, Rab8, Rab11, Rab21, Rab23, Rab25, Rab27B,
Rab35 and others (as reviewed in Table 1) promotes
tumor cell migration and invasion to exhibit their effects
on tumorigenesis and metastasis by regulating intracel-
lular signal transduction [39–49]. Elevated expression of
oncogenic Rab1 has been reported in several cancer
types and is associated with poor survival [50–53]. Over-
expression of Rab1A promotes mTORC1 signaling and
oncogenic growth in response to amino acids stimulation
and therefore enhances tumor progression and invasion in
colorectal cancer [50, 51]. In addition, gene amplification
and overexpression of Rab23 enhance cancer cell invasion
and correlate with advanced-stage gastric cancer [47].
Moreover, it has been recently shown that Rabs-
mediated vesicle dynamics cooperates with oncogenic
signaling pathway to promote tumorigenesis. Indeed,
Rab2A drives breast cancer stem cells expansion through
activation of Erk signaling [44]. High expression of
Rab25 has been frequently associated with poor progno-
sis in breast and ovarian cancer. Mechanistically, Rab25
expression promotes anti-apoptotic phosphoinositide 3-
kinase (PI3K)-Akt pathway and inhibits pro-apoptotic
molecules expression such as BAK thereby increasing
aggressiveness of cancer cells [48]. Recently, another
oncogenic Rab35 has been identified by two gain-of-
function mutations in tumor cells. It is proposed that
constitutively active Rab35 mediates internalization of
platelet-derived growth factor receptor α to LAMP2-
positive endosomal membrane, where it drives the acti-
vation of oncogenic PI3K/Akt signaling [49], suggesting
that Rabs-mediated vesicle dynamics and oncogenic sig-
naling cooperate to direct tumor progression.
Malfunction of Rabs-regulating vesicle trafficking could
promote cancer invasion. For example, Rab11 is an im-
portant component for membrane proteins recycling and
proteins transport from TGN to the plasma membrane
[54]. Rab11-mediated α6β4 integrin trafficking has been
found to contribute to increase cancer cell invasion in
breast cancer [39]. Similarly, Rab25 facilitates invasive cell
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migration by controlling α5β1 integrin trafficking through
the recycling endosomes [40]. Oncogenic Rab8 transports
exocytic vesicles carrying membrane type 1-matrix metal-
loproteinase (MT1-MMP) to the plasma membrane for
matrix degradation of migrating cancer cells cultured in
collagen gel [41]. In a similar scenario, through mass spec-
trometric analysis, heat-shock protein 90a has been identi-
fied as a component of Rab27B-regulated vesicles, acting
as a pro-invasive growth regulator required for activation
of matrix metalloproteinase 2 (MMP2). An increased ex-
pression of Rab27B is associated with the poor prognosis
of oestrogen receptor-positive breast cancer patients, sup-
porting the role of Rab27B in tumor promotion [42].
In contrast to the roles of Rabs in promoting tumor
progression, a minor fraction of Rabs is proposed to
serve as tumor suppressor (Table 1). However, Rab pro-
teins may have diverse functions in different types or
subtypes of cancers. For example, in addition to its role
in increasing invasiveness of cancer cells, Rab25 has also
been identified to act as a tumor suppressor by inhibit-
ing invasive and angiogenic activities in esophageal squa-
mous cell carcinoma [55] and by increasing malignant
tumor formation in the intestines of Rab25-/-;ApcMin/-
mice [56]. The oncogenic or tumor suppressive func-
tions of Rab25 are cell-type dependent. Rab25 enhances
the aggressiveness in ovarian and breast cancer cells
[48], while it functions as a tumor suppressor in esopha-
geal squamous cell carcinoma and colorectal carcinoma
[55, 56]. An explanation for the discrepancies is that the
role of Rab25 in tumorigenesis is dependent on specific
or a group of cancer type and on its interplay with cell-
type specific effectors.
Rab37 is another example of diverse functions in
different types of cancers. Upregulation of Rab37 and its
interacting partner TMEM22 are found in renal cell
carcinoma (RCC) and decrease in its level by siRNA re-
duces cancer cell growth, suggesting the oncogenic-like
role of Rab37 in RCC [57]. However, promoter hyperme-
thylation of Rab37 gene leading to low expression of
Rab37 mRNA and protein is associated with advanced
metastasis in non-small cell lung cancer patients [58].
These results may attributed to Rab-mediated cell-type
specific distinct downstream pathways or cargo trafficking.
Interestingly, Rab37-mediated exocytosis of tissue inhibi-
tor of metalloproteinase 1 (TIMP1) inactivates extracellu-
lar MMP9 and thereby suppresses cell invasion signaling
[59]. Of note, reconstituted TIMP1 by addition of TIMP1
recombinant protein abolishes the migration and invasion
ability of lung cancer cells in vitro and in vivo [59]. In
addition, 5-Aza-2-deoxycytidine treatment of a highly
Fig. 1 Schematic diagram showing the Rab proteins-mediated vesicular transport and signaling pathways in tumorigenesis. Rab family proteins play key
roles in regulating cellular membrane trafficking including endocytosis, exocytosis, exosome secretion as well as vesicles delivery between organelles. All of
these vesicles dynamics affects cellular physiology. Dysregulation of oncogenic Rabs at the protein levels or activity such as Rab1, Rab25 and Rab35 exerts
tumor-promoting properties such as anti-apoptosis, increase in proliferation, invasion and migration through activation of various signaling pathways. For
example, Rab2A facilitates Erk1/2 activation and thus leads to Zeb1 upregulation and β-catenin nuclear translocation, then promotes tumor initiation. In
contrast, malfunction of tumor suppressor Rabs promotes oncogenesis and tumor progression. For example, Rab37 delivers its cargo TIMP1 to
inhibit MMP9 activity leading to suppression of tumor motility, while loss of Rab37-mediated TIMP1 secretion promotes tumor metastasis.
Arrows indicate vesicular movement regulated by Rab proteins. Thick arrows represent Rabs-mediated signaling pathways involved in
tumorigenesis and tumor suppression. Note that some organelles and vesicles are relatively enlarged to emphasize the pathways involved
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metastatic lung cancer cell line shows demethylation and
re-expression of the Rab37 gene and correlates with
reduced cancer cell migration [58]. The last-mentioned
two studies provide therapeutic strategies such as DNA
demethylation of Rab37 gene and increased expression of
Rab37 protein and its cargos such as TIMP1 could facili-
tate the development of anti-cancer treatment.
Rab GTPases regulators mediate cancer progression
Dysregulated interaction between Rabs and their effec-
tors could also link to tumor progression and malig-
nancy. Effector proteins including GEFs, GAPs and
GDIs together with tethering factors and SNAREs play
key roles in regulating Rab GTPase function as molecu-
lar switches by cycling between active membrane-bound
GTP and inactive cytosolic GDP-bound forms. For ex-
ample, numerous effectors for Rab5 have been identified,
including Rabaptin-5, Vac1, early endosome antigen 1
(EEA1), PI3K, and Class C core vacuole/endosome teth-
ering (CORVET). Increased expression of Rabaptin-5, a
Rab effector interacting with GTP-bound Rab5, acceler-
ates endocytosis of epidermal growth factor receptor via
Rab5-mediated endosomal fusion pathway and subse-
quently affects tumor progression [60, 61]. The effector
of Rab11, Rab11-family interacting protein 2 (Rab11-
FIP2), has been implicated in regulation of recycling
endosomal trafficking through interaction with Rab11a
[62]. Rab11-FIP2 increases epithelial-mesenchymal tran-
sition and metastasis in gastric cancer [63]. Rab11-FIP2
also promotes colorectal cancer cells migration and
invasion by upregulating MMP7 expression through
activating PI3K/Akt signaling [64]. In contrast, Rab11-
FIP1C, another effector of Rab11, acts as a tumor sup-
pressor in ErbB2-mediated breast cancer [65]. DENND2B,
a GEF for Rab13, activates Rab13-mediated exocytosis and
enhances the invasiveness of cancer cells. Disruption of
Rab13-mediated trafficking limits the spread of epithelial
cancer cells [66, 67].
Moreover, alteration of SNARE complex has been shown
to involve in tumorigenesis. SNARE complex are composed
of vesicle associated SNAREs (v-SNARE) and SNAREs at
targeting membrane (t-SNAREs). The trans-SNAREs for-
mation by interaction of v-SNAREs with t-SNAREs allows
the fusion of vesicle and acceptor membrane. Notably, an
increase in interaction between Syntaxin6 and Rab11/
vesicle-associated membrane protein 3 (VAMP3) on recyc-
ling endosome inhibits αvβ1 and αvβ3 integrins recycling
and suppresses cell migration [68]. Conversely, Rab7 and
Table 1 Oncogenic and tumor suppressor Rab proteins in cancers
Rab protein Cancer types Expression Clinical implications References
Rab1 Colon Increased Elevated cell invasion,
poor prognosis
[50]
Liver Increased Elevated cell invasion,
poor prognosis
[51]
Brain Increased Poor survival [52]
Rab2 Breast Increased Expansion of stem-like cells,
poor prognosis
[44]
Rab3 Breast Increased Elevated cell motility [45]
Brain Increased Tumor progression [81]
Rab4 Breast Increased Elevated cell motility [82]
Rab5 Lung Increased activity Elevated cell motility [83]
Rab11 Breast Increased activity Elevated cell invasion [39]
Rab17 Liver Decreased Elevated clinical tumor
characteristics
[84]
Rab21 Cervical cancer Increased Elevated cell motility [46]
Rab23 Stomach Increased Poor prognosis [47]
Rab25 Ovarian, Breast Increased Poor prognosis [48]
Esophagus Decreased Poor survival [55]
Colon Decreased Poor survival [56]
Rab27 Breast Increased Poor prognosis [42]
Rab31 Breast Increased Poor survival [85]
Rab35 Not applicable Gain of function mutations Anti-apoptosis [49]
Rab37 Lung Decreased Poor prognosis [58, 59]
Rab38 Brain Increased Poor prognosis [86]
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VAMP7 cooperatively mediate endosomal recycling of
membrane type MT1-MMP to promote cancer cells migra-
tion and invasion [69]. These findings reveal that the effec-
tors and SNAREs of Rabs-mediated membrane trafficking
are involved in tumorigenesis. Nevertheless, more research
is needed to better understand the complexity of the inter-
action between Rabs-effectors-SNAREs.
Rabs and Rab effectors in tumorigenic signalings
Phosphorylation of Rab proteins is important for vesicle
targeting and traffic. Rab5a has been reported to be
phosphorylated by PKCε to facilitate T-cell migration
[70]. Mechanistically, phosphorylated Rab5a promotes
Rac1 activation to facilitate actin remodeling. Conven-
tional PKC-mediated Rab11 and Rab6 phosphorylation
results in impaired endosomal recycling and redistribu-
tion in cytosolic fraction, respectively [71, 72]. Studies
have shown that phosphorylation of Rab4 by p34cdc2
prevents the association of Rab4 with endosomal mem-
brane by dissociating its binding to membrane effector
during the cell cycle [73, 74]. Interestingly, dephosphory-
lation of Rab7 by PTEN is important for its membrane
targeting and subsequent activation, suggesting that
phosphorylation status is critical for regulating Rab7
endosomal localization and activity [75]. Rab8A phosphor-
ylation on Ser111 is also observed to impair its binding to
Rabin8, the GEF for Rab8A that triggers GDP exchange
[76]. However, the significance of post-translational modi-
fications in the regulation of Rab GTPase activity is poorly
defined. The clinical relevance of the modifications such
as phosphorylation of Rabs in human cancers still remains
largely uncharacterized.
In addition, phosphorylation-dependent regulation of
Rabs effectors plays important roles in coordinating
Rabs-mediated vesicle trafficking. For example, connec-
denn1/2 are identified as GEFs for Rab35. Akt-mediated
connecdenn 1/2 phosphorylation promotes the inter-
action of Rab35 and its GEF [77]. Unc-51-like kinases
have been reported to phosphorylate DENND3 and up-
regulate its GEF activity toward Rab12. Activation of
Rab12 facilitates autophagosome trafficking in response
to starvation [78]. Accordingly, phosphorylation of Ra-
bin8, a GEF for Rab8, by ERK1/2 increases its GEF activ-
ity and promotes recycling of transferrin to the plasma
membrane [79]. Importantly, dysregulated phosphoryl-
ation of Rabs effectors involves in tumorigenesis. For
example, Rabaptin-5, a Rab5 effector in endosomal
membrane fusion, is a protein kinase D (PKD) substrate.
Interestingly, phosphorylated Rabaptin-5 interacts pref-
erentially with Rab4, but not Rab5, to promote αvβ3
recycling leading to enhanced cell motility and invasion
[80]. The oncogenic signaling pathways of Rab effec-
tors in promoting tumor development or suppressing
tumorigenesis need further elucidation.
Conclusion
Taken together, as key regulators of cargo transport in
vesicle trafficking, it is not surprising that Rab proteins
have been linked to tumorigenesis or tumor prevention.
Vesicle delivery and dynamics are critical for regulation
of cell behaviors associated with cell migration/invasion
and tumorigenesis. Notably, specific Rab proteins may
have diverse functions in different types or subtypes of
cancers. Although mutations or alterations in expression
of the components of vesicle transporting machinery
may not directly drive cell transformation, cooperation
between Rabs and effectors in mediating vesicle move-
ment pathways has critical influences on tumor progres-
sion and malignancy. Therefore, it raises the possibility
that targeting particular trafficking system may provide a
new approach to cancer treatment.
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